Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0000905148-26-003351

Chief Financial Officer sold 7,783 shares at $2.95 ($22,942)

From the SEC's structured data for this filing

Trades in this filing

Gagnon Robert E. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-23 Sale : show line 1 in the form −7,783 $2.95 $22,942 584,375 D
Open-market sales · 7,783 sh · avg $2.95 · $22,942
Loading xslF345X06/form4.xml…